Loading...
Emerging epigenetic-modulating therapies in lymphoma
Despite considerable advances in the treatment of lymphoma, the prognosis of patients with relapsed and/or refractory disease continues to be poor; thus, a continued need exists for the development of novel approaches and therapies. Epigenetic dysregulation might drive and/or promote tumorigenesis i...
Saved in:
| Published in: | Nat Rev Clin Oncol |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2019
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6650343/ https://ncbi.nlm.nih.gov/pubmed/30837715 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41571-019-0190-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|